PubRank
Search
About
Beverly Lange
Author PubWeight™ 22.93
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Communication of randomization in childhood leukemia trials.
JAMA
2004
3.20
2
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood
2002
2.76
3
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
2009
2.36
4
Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
J Clin Oncol
2003
1.93
5
Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group.
Cancer Epidemiol Biomarkers Prev
2005
1.39
6
Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.
Blood
2004
1.27
7
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
J Clin Oncol
2010
1.26
8
Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Pediatr Blood Cancer
2007
1.18
9
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood
2010
1.16
10
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Cancer Res
2005
1.13
11
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.
Blood
2005
1.08
12
Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
J Clin Oncol
2004
0.97
13
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.
Br J Haematol
2003
0.95
14
Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.
Br J Haematol
2004
0.89
15
Germline genetic variation and treatment response on CCG-1891.
Pediatr Blood Cancer
2011
0.84